On March 11, 2024, Kao Corporation and istyle Inc. jointly established the RNA Co-creation Consortium, centering on Kao's sebum RNA monitoring^*1 technology. Through the Consortium, the companies aim to achieve business co-creation and sustainable growth of the beauty and health industries.

Kao, which will provide sebum RNA monitoring technology, and istyle, Japan's largest beauty-specialized platform, will serve as directors of the Consortium and have set up a steering committee. Co-creation partners KOSÉ Corporation, MatsukiyoCocokara & Co., Kirin Holdings Company, Limited, Perfect Corp. and Healthcare Systems Co., Ltd., all leading companies in their respective fields, will act as coordinator companies.

The future aim of the Consortium is to create a framework, based on RNA information, that offers consumers a more satisfying selection of personalized products and services. At the same time, by fine-tuning supply and demand, the Consortium hopes to establish a sustainable consumption cycle that does not burden people or the environment.

• *1 Kao News Release dated June 10, 2019
  Kao's original non-invasive analytical method for monitoring RNA - Discovery of the presence of human RNA in sebum